-
1“... in the draft FDA guidance does not take in consideration different sources of variation. Therefore, we apply...”
Get full text
Others -
2“... for the in-vitro population bioequivalence (PBE) proposed by the draft guidance of the US FDA consists...”
Get full text
Others